Testicular & Prostate Cancer

Prostate and Testicular Cancer are the most common forms of male cancer, affecting thousands of men every year. Learn more about the survival rates, treatments and the many excellent support groups and leading hospitals here.

If you would like to contribute vital information, please do get in touch.

Testicular Cancer and Prostate Cancer Treament Types

Prostate Cancer Treatments

 The latest treatment options somewhat confusing where each has its pros and cons. No single treatment is right for every man with prostate cancer and will vary with

Early stage prostate cancer

Early-stage prostate cancer refers to cancer that is contained entirely within the prostate gland. It has not spread -- metastasized -- either to local tissues or to distant body parts, such as bone. This type of cancers is the most curable.

There are three basic options for early stage prostate cancer. The two active treatment options, surgery and radiation can often lead to a cure when used alone. Men with intermediate-risk or high-risk disease usually need a combination of therapies to achieve a high likelihood of cure or disease control.

The three options for early-stage/low-risk prostate cancer are:

The third option is not actually a form of treatment. Instead, it's a form of close patient management.

There is a fourth basic treatment option: hormone therapy. It is usually reserved for older men too debilitated for active treatment and for treatment of men with more advanced disease.

Chemotherapy plays only a limited role in prostate cancer treatment. It's reserved primarily for the treatment of men with advanced or recurrent prostate cancer that does not respond to hormone therapy.

The choice of surgery, radiation, or expectant management may depend on several factors:

Testicular Cancer Treatment

The options for treating testicular cancer depend on several factors, including the type and stage of cancer, overall health, and personal preferences. Treatment options may include:

Development of Testicular Cancer Treatments - Carboplatin

In the 1960s, the survival rate was shockingly low: Only six per cent of men survived the disease. These days, the cure rate is 99% if caught early enough, largely due to successful treatments called cisplatin and carboplatin. Carboplatin was developed at The Institute of Cancer Research (ICR), home of the Everyman Centre.